Shopping Cart
- Remove All
- Your shopping cart is currently empty
GST-HG131, a dihydrobenzopyridooxazepine (DBP) series compound, specifically inhibits hepatitis B virus (HBV) surface antigen. It demonstrates excellent HBV antigens inhibition, with EC50 values of 28.2 nM (HBsAg) and 16.0 nM (HBeAg), respectively, and is safe for animal use.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,650 | 10-14 weeks | |
50 mg | $2,150 | 10-14 weeks | |
100 mg | $3,310 | 10-14 weeks |
Description | GST-HG131, a dihydrobenzopyridooxazepine (DBP) series compound, specifically inhibits hepatitis B virus (HBV) surface antigen. It demonstrates excellent HBV antigens inhibition, with EC50 values of 28.2 nM (HBsAg) and 16.0 nM (HBeAg), respectively, and is safe for animal use. |
Molecular Weight | 431.48 |
Formula | C23H29NO7 |
Cas No. | 2270215-69-3 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.